miR-128 Functions as an OncomiR for the Downregulation of HIC1 in Breast Cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Hypermethylated in cancer 1 (HIC1) expression is decreased in breast cancer tissues.
• The regulatory mechanisms controlling HIC1 levels in breast cancer are not fully understood.

Purpose of the Study:

• To investigate the role of microRNA-128 (miR-128) in regulating HIC1 expression in breast cancer.
• To elucidate the functional consequences of HIC1 suppression by miR-128 on breast cancer progression.

Main Methods:

• Bioinformatic analysis to predict miR-128 targeting of HIC1.
• Experimental validation of HIC1 as a direct target of miR-128 through overexpression and knockdown studies.
• Assessment of cell invasion, proliferation, and apoptosis in response to miR-128 modulation.
• In vivo studies using xenograft mouse models to evaluate tumor growth.

Main Results:

• HIC1 was confirmed as a direct target gene of miR-128.
• Suppression of HIC1 by miR-128 led to increased breast cancer cell invasion and proliferation.
• miR-128-mediated HIC1 inhibition resulted in reduced apoptosis.
• In vivo, miR-128 accelerated tumor growth by downregulating HIC1.

Conclusions:

• This study establishes miR-128 as a key regulator that suppresses HIC1 expression in breast cancer.
• The miR-128/HIC1 axis plays a significant role in promoting breast cancerogenesis.
• Targeting the miR-128/HIC1 pathway may offer a novel therapeutic strategy for breast cancer.